Back to MW MARSHALL WACE, LLP

IMCRIMCR
Showing 8 of 19 quarters

Position history for MWMARSHALL WACE, LLP's holdings in IMMUNOCORE HLDGS PLC

MARSHALL WACE, LLP holds 590,941 shares of IMCR (IMMUNOCORE HLDGS PLC), worth $18.8M as of 2026-Q2. The position was increased (+227.7% shares). IMCR represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$18.8M

Current Shares

590,941

Total Value Change

+$12.6M

Total Shares Change

+391,498

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
590,941
+227.7%
$18.8M0.0%$31.75
46
2026-Q1
Increased
180,340
+194.8%
$5.4M0.0%$32.36
44
2025-Q4
Decreased
61,163
-50.4%
$2.1M0.0%$34.10
0
2025-Q3
Decreased
123,242
-15.9%
$4.5M0.0%$34.34
0
2025-Q2
Increased
146,610
+425.8%
$4.6M0.0%$31.12
43
2025-Q1
Decreased
27,882
-2.5%
$827,2580.0%$29.58
0
2024-Q4
Decreased
28,610
-85.7%
$843,9980.0%$29.03
0
2024-Q3
Decreased
199,443
-19.8%
$6.2M0.0%$31.40
0

Other major holders of IMCR: RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used